| Stage | OSW | % of rev | ACLS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $277M | 100.00% | $215M | 100.00% | OSW ×1.29 |
| Gross profit | $50M | 17.97% | $91M | 42.38% | ACLS +24.4pp |
| Operating income | $30M | 10.83% | $20M | 9.43% | OSW +1.4pp |
| Pre-tax income | $29M | 10.40% | $25M | 11.78% | ACLS +1.4pp |
| Net income | $28M | 10.21% | $23M | 10.82% | ACLS +0.6pp |
| Stage | OSW | ACLS | Gap · A − B |
|---|---|---|---|
| Revenue | $277M100.00% | $215M100.00% | OSW ×1.29 |
| Gross profit | 17.97%$50M | 42.38%$91M | ACLS +24.4pp |
| Operating income | 10.83%$30M | 9.43%$20M | OSW +1.4pp |
| Pre-tax income | 10.40%$29M | 11.78%$25M | ACLS +1.4pp |
| Net income |
| 10.21%$28M |
| 10.82%$23M |
| ACLS +0.6pp |
None
No disclosed counterparties: OSW.